Latest Headlines
- 
                    Mopec Expands Partnership With Lumea To Deliver Seamless Digital Pathology Integration And Consumables Access
                        9/28/2025
                    
Mopec, a leader in pathology and anatomy innovation, is proud to announce the next chapter in its collaboration with Lumea, a pioneer in digital pathology technology.
 - 
                    ASCP Launches Advanced Analytics And Benchmarking Platform To Transform Laboratory Performance
                        9/26/2025
                    
The American Society for Clinical Pathology (ASCP) has launched Performance and Diagnostics Insights (PDI), a groundbreaking platform designed to transform how healthcare organizations harness clinical and anatomic pathology laboratory data to assess performance and areas for improvement to elevate patient care.
 - 
                    StatLab Leads Pathology Innovation With U.S. Diapath Equipment Launch
                        9/26/2025
                    
StatLab Medical Products, a leading developer and manufacturer of pathology supplies and equipment, today announced the U.S. commercial launch of Diapath signature Pathology instruments.
 - 
                    Entered A Partnership With ELITech In The Field Of Molecular Testing For Infectious Disease
                        9/25/2025
                    
Hitachi High-Tech Corporation ("Hitachi High-Tech"), and ELITechGroup S.p.A. (Head Office: Italy, "ELITech") have entered a Collaboration, Manufacturing and Supply Agreement (the "Agreement") in the field of molecular testing for infectious disease.
 - 
                    New Research Reinforces C2N's PrecivityAD2 Blood Test As A Highly Accurate Tool To Detect Brain Amyloid Pathology In Symptomatic Patients
                        9/25/2025
                    
C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation, is highlighting a peer-reviewed study that independently validates the performance of the PrecivityAD2 blood test among individuals with mild cognitive impairment or dementia.
 - 
                    LigoLab And PathPresenter Announce Strategic Partnership To Deliver Seamless Digital Pathology Workflows
                        9/25/2025
                    
LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader in digital pathology image viewing and management solutions, today announced a strategic partnership.
 - 
                    Multiple South West London Pathology Trusts Select Indica Labs And Leica Biosystems For Advancing Digital Pathology In Clinical Practice
                        9/24/2025
                    
Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announce today that multiple trusts within the South West London Pathology network have chosen the powerful combination of Leica Biosystems Aperio GT 450 DX scanners and Indica Labs’ HALO A for digital pathology adoption.
 - 
                    Guardant Health And Quest Diagnostics Announce Strategic Collaboration To Broaden Access To Guardant's Shield Blood-Based Screening Test In The United States
                        9/24/2025
                    
Guardant Health, Inc. a leading precision oncology company, and Quest Diagnostics a leader in diagnostic information services, today announced a broad strategic collaboration to make Guardant’s Shield blood-based screening test available to physicians and patients served by Quest in the United States.
 - 
                    Proscia To Expand Pathology AI Capabilities With Virtual Staining
                        9/24/2025
                    
Proscia®, a pathology AI company, is introducing virtual staining in its Concentriq® software platform to help laboratories reduce the costs associated with traditional chemical methods and drive efficiency in high-throughput workflows.
 - 
                    Lunit, CellCarta Announce Global Alliance To Expand Access To Digital Pathology AI For Clinical Trials
                        9/24/2025
                    
Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and biomarkers for oncology therapeutics, today announced a strategic partnership with CellCarta, a globally recognized provider of CRO laboratory services for pharmaceutical research and development.